[1] |
殷金兰,李莹,陈金梅,等. 4项肿瘤标志物检测在晚期非小细胞肺癌治疗中的意义[J]. 国际检验医学杂志,2017,38(14):1985-1987.
|
[2] |
许子寒,郑林鹏,杨峤,等. 非小细胞肺癌的转移特征及预后分析[J]. 第三军医大学学报,2019,41(9):871-876.
|
[3] |
ZHANG E,XU Z,DUAN W,et al.Association between polymorphisms in pre-miRNA genes and risk of oral squamous cell cancer in a Chinese population[J]. PLoS One,2017,12(6):e0176044.
|
[4] |
崔胜金,曹朝鹏,郭伟权,等. 非小细胞肺癌早期诊断的潜在生物标志物:血浆miRNA-23a和miRNA-451[J]. 南方医科大学学报,2019,39(6):705-711.
|
[5] |
GUO W,ZHANG Y,ZHANG Y,et al.Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer[J]. Int J Mol Med,2015,36(6):1720-1726.
|
[6] |
YU F,LIU J B,WU Z J,et al.Tumor suppressive microRNA-124a inhibits stemness and enhances gefitinib sensitivity of non-small cell lung cancer cells by targeting ubiquitin-specific protease 14[J]. Cancer Lett,2018,427:74-84.
|
[7] |
HE Y M,JI A J,XU X Y,et al.miR-449a:a potential therapeutic agent for cancer[J]. Anticancer Drugs,2017,28(10):1067-1078.
|
[8] |
袁双虎,于金明. 《原发性肺癌诊疗规范(2015年版)》放射治疗更新解读[J]. 中国医师杂志,2016,18(6):801-804.
|
[9] |
FERNANDES S L,GURUPUR V P,LIN H,et al.A novel fusion approach for early lung cancer detection using computer aided diagnosis techniques[J]. J Med Imaging Health Inf,2017,7(8):1841-1850.
|
[10] |
SHANG X,ZI H,LI Y,et al.Combined use of salivary biomarkers and carcinoembryonic antigen for lung cancer detection in a Chinese population[J]. Medicine(Baltimore),2019,98(31):e16511.
|
[11] |
WONG N W,CHEN Y,CHEN S,et al.OncomiR:an online resource for exploring pan-cancer microRNA dysregulation[J]. Bioinformatics,2018,34(4):713-715.
|
[12] |
NIXON A M,PROVATOPOULOU X,KALOGERA E,et al.Circulating thyroid cancer biomarkers:current limitations and future prospects[J]. Clin Endocrinol(Oxf),2017,87(2):117-126.
|
[13] |
YOU Z,HUANG Z A,ZHU Z X,et al.PBMDA:a novel and effective path-based computational model for miRNA-disease association prediction[J]. PLoS Comput Biol,2017,13(3):e1005455.
|
[14] |
LANG F M,HOSSAIN A,GUMIN J,et al.Mesenchymal stem cells as natural bio-factories for exosomes carrying miR-124a in the treatment of gliomas[J]. Neuro Oncol,2018,20(3):380-390.
|
[15] |
DENG N,LI L,GAO J,et al.Hsa_circ_0009910 promotes carcinogenesis by promoting the expression of miR-449a target IL6R in osteosarcoma[J]. Biochem Biophys Res Commun,2018,495(1):189-196.
|
[16] |
SUN X,LIU S,CHEN P,et al.miR-449a inhibits colorectal cancer progression by targeting SATB2[J]. Oncotarget,2016,8(60):100975-100988.
|
[17] |
邓雪松,潘红艳,成俊,等. 上调miR-449a表达对肝癌细胞生长和侵袭能力的影响[J]. 中国普通外科杂志,2018,27(1):68-74.
|
[18] |
SHINTANI T,MATSUO Y,IIZUKA Y,et al.Prognostic significance of serum nse for non-small cell lung cancer patients receiving stereotactic body radiotherapy[J]. Anticancer Res,2017,37(9):5161-5167.
|
[19] |
BARNETT D,LIU Y,PARTYKA K,et al.Abstract 1754:a new glycan biomarker for pancreatic cancer complements CA19-9 and identifies a distinct subpopulation of cancer cells[J]. Cancer Res,2017,77(13):1754.
|